• Mail Us services@iebrain.com
  • US | INDIA +1-202-697-9162 | +91-124-429-4218

Global COVID-19 Testing – Opportunities and Roadmap 

The coronavirus (COVID-19) pandemic has now spread to nearly every country on the planet. The overall number of cases are greater than the number of confirmed cases. Low availability of test kits and sensitivity/specificity issues associated with a set of current kits are the key detrimental factors in timely medication. Inadequate testing capacity for SARS CoV-2 creates potential opportunities for diagnostic device companies by collaborating with other players to boost their manufacturing capacity and delivering adequate testing kits.

According to our report, diagnostic and medical device companies with capabilities of developing Molecular Assays, Immunoassays, Serological testing and Digital Solutions have great opportunities to grow in a fiercely competitive market and help countries in fighting against coronavirus (COVID-19) pandemic. Key Molecular diagnostic techniques used in the SARS CoV-2 detection kits are Reverse transcription polymerase Chain reaction (RT-PCR), Enzyme-linked Immunosorbent Assay (ELISA) and Next-generation sequencing (NGS). Artificial intelligence (AI) based systems are rapidly used for the diagnosis of COVID19 as they can easily process computed tomography (CT) images in seconds to speed up the diagnosis of COVID-19.

Key players in the domain such as Altona Diagnostics, Roche Diagnostics, Thermo Fisher Scientific, Qiagen, Euroimmun Ag and Illumina. Emerging players in the domain are Aperiomics (US), Fulgent Genetics (US), Co-Diagnostics (US), CTK Biotech (US), Medical Innovation Ventures (US), Gene Biosystems (Europe), GeneFirst (Europe), Camtech Diagnostics (APAC), SensingSelf (APAC), NanoBio Lab (APAC), Optolane Technologies (APAC) and GenBody (APAC). The report benchmarks the regulatory status of existing kits, technology used, pricing and other USPs.

The study presents opportunities for other companies such as Nector Life Sciences, Agilent technologies, Agena Bioscience and Pacific Bioscience in developing a future-fit development strategy and analytics to support their business decisions during this special period.

The key events held in concerning the development of COVID-19 diagnostics are also highlighted in the report. Further, various business models and evolving value chain will also help users in preparing their road map.

1. Executive Summary

2. Introduction

2.1 Objective of the Study

2.2 Study Scope

3. Methodology

3.1 IEBS Approach

3.2 Research Methodology

4. COVID-19 Testing Overview

4.1 Testing Methods

4.2 Technology Clustering

4.3 Techniques with Future Potential

5. COVID-19 Diagnostic/Testing Kits Market

5.1 Current Ecosystem

5.2 Market by Value

5.3 Market by Volume

5.4 Supply Chain Analysis

6. Global Challenge

6.1 Tests Performed v/s Confirmed Cases

6.2 Inadequacy of Diagnostic Tests Worldwide

6.3 Re-occurrence of positive cases in second wave

7. Solutions for Global Challenges

7.1 Rapid Detection Kits

7.2 Point of Care Diagnosis

7.3 Streamlined Supply Chain

8. Competitive Scenario

8.1 Value Chain Analysis

8.2 Integrated Manufacturers

8.3 Component Suppliers

8.4 Start-ups/Emerging Players

9. Key Companies and Benchmarking of their Technologies

9.1 Altona Diagnostics

9.2 Roche Diagnostics

9.3 Thermo Fisher Scientific

9.4 Euroimmun Ag

9.5 Qiagen

9.6 XXX

10. Emerging Players Region-wise (Europe, US and APAC)

10.1 Co-Diagnostics

10.2 CTK-Biotech

10.3 Medical Innovation Ventures Sdn Bhd.

10.4 Gene Biosystems

10.5 GeneFirst Ltd.

10.6 Camtech Diagnostics Pte Ltd

10.7 SensingSelf Pte Ltd

10.8 XXX

11. Actionable Insights

11.1 Key Opportunities for Diagnostic Testing Companies

11.2 Opportunity Matrix

11.3 Potential Partners for Collaboration

12. Future Outlook

12.1 Pricing and Reimbursements (Region wise)

12.2 Innovations in Testing Kits

12.3 Business Models and Evolving Value Chain

13. Roadmap and Opportunities for Other Companies

13.1 Nector Life Science

13.2 Agilent Technologies

13.3 Agena Bioscience

13.4 Pacific Bioscience

13.5 XXX

14. Annexure

BUY NOW

Name*


Email Address*


Phone Number*


Company*


Job Title*


Country*

Select User License*


REQUEST SAMPLE

Name*


Email Address*


Phone Number*


Company*


Tell Us What You're Interested In*


Area of interest*


Country*

What Can We Do For You?*


ENQUIRY BEFORE BUYING

Name*


Email Address*


Phone Number*


Company*


Tell Us What You're Interested In*


Area of interest*


Country*

What Can We Do For You?*


ASK fOR CUSTOMISATION

Name*


Email Address*


Phone Number*


Company*


Tell Us What You're Interested In*


Area of interest*


Country*

What Can We Do For You?*


ENQUIRY BEFORE BUYING

Name*


Email Address*


Phone Number*


Company*


Tell Us What You're Interested In*


Area of interest*


Country*

What Can We Do For You?*


REQUEST SAMPLE

Name*


Email Address*


Phone Number*


Company*


Tell Us What You're Interested In*


Area of interest*


Country*

What Can We Do For You?*


ASK fOR CUSTOMISATION

Name*


Email Address*


Phone Number*


Company*


Tell Us What You're Interested In*


Area of interest*


Country*

What Can We Do For You?*